Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Prostate cancer transfection by acoustic energy using pEGFP-N1 as reporter gene in the solid Dunning R-3327-MatLu tumor

Prostate Cancer and Prostatic Diseases volume 6, pages 290–293 (2003)Cite this article

Abstract

Background: Gene therapy is expected to play a major role in medical treatment in the future. Several different methods for DNA transfection exist. We evaluated the efficacy and effects of transfection by acoustic energy in a standardized prostate cancer model.

Methods: Subcutaneous implantation of Dunning tumors was followed by injection of pEGFP-DNA plasmid. Tumors were treated by acoustic energy with different parameter settings and the transfection rate was assessed by FACScan.

Results: Standardized experimental conditions resulted in minor intragroup deviations. Intratumoral injection resulted in a transfection rate of 0.3% (control group). The statistically significant increase of 4.6% in cell transfection rate was gained by applying acoustic energy.

Conclusions: DNA transfection of solid tumors can be mediated by the application of acoustic energy. Achieved transfection rates are encouraging and imply therapeutical levels. Prodrug activation or suicide gene therapy are possible fields of investigation in the treatment of prostate cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Verma I, Somia N, Gene therapy—promises, problems and prospects. Nature 1997; 389: 239–242.

    Article  CAS  Google Scholar 

  2. Doehmer J et al. Introduction of rat growth hormone gene into mouse fibroblasts via a retroviral DNA vector: expression and regulation. Proc Natl Acad Sci USA 1982; 79: 2268–2272.

    Article  CAS  Google Scholar 

  3. Lohr F et al. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. Cancer Res 2001; 61: 3281–3284.

    CAS  Google Scholar 

  4. Capecchi MR . High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 1980; 22: 479–488.

    Article  CAS  PubMed  Google Scholar 

  5. Gambihler S, Delius M, Ellwart JW . Permeabilization of the plasma membrane of L1210 mouse leukaemia cells using lithotripter shock waves. J Membr Biol 1994; 141: 267–275.

    Article  CAS  PubMed  Google Scholar 

  6. Miller N, Vile R . Targeted vectors for gene therapy. FASEB J 1995; 9: 190–199.

    Article  CAS  PubMed  Google Scholar 

  7. Lauer U et al. Shock waves permeabilization as a new gene transfer method. Gene Therapy 1997; 4: 710–715.

    Article  CAS  PubMed  Google Scholar 

  8. Bao S, Thrall BD, Miller DL . Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol 1997; 23: 953–959.

    Article  CAS  PubMed  Google Scholar 

  9. Michel MS, Köhrmann KU, Siegsmund M, Alken P . Acoustic energy for genomic engineering of prostate cancer cells. BJU Int 2000; 86 (Suppl 3): 151.

    Google Scholar 

  10. Delagrave S et al. Red-shifted excitation mutants of the green fluorescent protein. Biotechnology 1995; 13: 151–154.

    CAS  Google Scholar 

  11. Shirakawa T et al. Tissue-specific promoters in gene therapy for the treatment of prostate cancer. Mol Urol 2000; 4: 73–82.

    Article  CAS  PubMed  Google Scholar 

  12. Thompson TC . In situ gene therapy for prostate cancer. Oncol Res 1999; 11: 1–8.

    CAS  Google Scholar 

  13. Voeks D et al. Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models. Gene Therapy 2002; 9: 759–768.

    Article  CAS  PubMed  Google Scholar 

  14. Palapattu GS, Naitoh J, Belldegrun AS . Gene therapy for prostate cancer. New perspectives on an old problem. Urol Clin N Am 1999; 26: 353–363.

    Article  CAS  Google Scholar 

  15. Fiedler M et al. Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine. Vaccine 2001; 19: 4618–4626.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University Hospital Mannheim, Germany

    M S Michel, P Erben, L Trojan, T Knoll & P Alken

Authors
  1. M S Michel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Erben
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Trojan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T Knoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Alken
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M S Michel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Michel, M., Erben, P., Trojan, L. et al. Prostate cancer transfection by acoustic energy using pEGFP-N1 as reporter gene in the solid Dunning R-3327-MatLu tumor. Prostate Cancer Prostatic Dis 6, 290–293 (2003). https://doi.org/10.1038/sj.pcan.4500667

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500667

Keywords

Search

Advanced search

Quick links